Cue Biopharma, Inc. (CUE) Q2 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cue Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.858 -- 00:00:04.923 Greetings and welcome to the QBioPharma Investor Update Call. 00:00:04.923 -- 00:00:08.527 At this time, all participants are in a listen-only mode. 00:00:08.527 -- 00:00:11.891 A question and answer session will follow the presentation. 00:00:11.891 -- 00:00:15.935 If anyone should require operator assistance during the conference, please press star 00:00:15.935 -- 00:00:21.382 zero on your telephone keypad. As a reminder, this conference is being recorded. 00:00:21.382 -- 00:00:26.428 I would now like to turn the conference over to Dan Passeri, QBioPharma's Chief Executive 00:00:26.428 -- 00:00:29.765 Officer. Thank you. You may begin. 00:00:29.765 -- 00:00:33.529 All right, thank you very much, and good afternoon, everyone. 00:00:33.529 -- 00:00:38.134 As a reminder, this presentation and discussion is being recorded and will be available 00:00:38.134 -- 00:00:43.380 on our website for the next 30 days. Also, please be aware that the slides accompanying 00:00:43.380 -- 00:00:48.045 today's update may be advanced directly by those listening in on the call, and we'll 00:00:48.045 -- 00:00:52.109 be notifying you as we proceed through the presentation. 00:00:52.109 -- 00:00:55.735 Joining me on today's call is Dr. Anish Suri. 00:00:55.735 -- 00:00:58.440 our President and Chief Scientific Officer, Dr. 00:00:58.440 -- 00:01:03.909 Matteo Levassetti, our Chief Medical Officer, and Carrie Ann Millar, our 00:01:03.909 -- 00:01:09.698 Chief Financial Officer. As shown on slide number two, this 00:01:09.698 -- 00:01:14.506 presentation and overview may contain some forward-looking statements, and any forward-looking 00:01:14.506 -- 00:01:18.994 statement made during this call represents the company's views only as of today, August 00:01:...